Article
Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Blood - 15 Jul 1999
Larson R A, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau M M, Smith M T
Abstract excerpt
NAD(P)H:quinone oxidoreductase (NQO1) converts benzene-derived quinones to less toxic hydroquinones and has been implicated in benzene-associated hematotoxicity. A point mutation in codon 187 (Pro to Ser) results in complete loss of enzyme activity in homozygous subjects, whereas those with 2 wild-type alleles have normal activity. The frequency of homozygosity for the mutant allele among Caucasians and African...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
